NeoGenomics, Inc. (NEO)
NeoGenomics Market Cap: 1.554B for Dec. 10, 2025
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| EXACT Sciences Corp. | 19.18B |
| IQVIA Holdings, Inc. | 37.96B |
| Incyte Corp. | 18.68B |
| Regeneron Pharmaceuticals, Inc. | 76.32B |
| Arcturus Therapeutics Holdings, Inc. | 217.92M |
Market Cap Related Metrics
| PS Ratio | 2.163 |
| PEG Ratio | -0.3056 |
| Price to Book Value | 1.854 |
| Price | 12.01 |
| Earnings Yield | -7.39% |
| PEGY Ratio | -0.3056 |